Land: Bretland
Tungumál: enska
Heimild: MHRA (Medicines & Healthcare Products Regulatory Agency)
Senna fruit
Alissa Healthcare Research Ltd
A06AB06
Senna fruit
7.5mg
Oral tablet
Oral
No Controlled Drug Status
Valid as a prescribable product
BNF: 01060200
PATIENT INFORMATION LEAFLET SENNOSIDES 7.5 MG TABLETS READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. Always take this medicine exactly as described in this leaflet or as your pharmacist has told you. • Keep this leaflet. You may need to read it again • Ask your pharmacist if you need more information or advice • If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4 • You must talk to a doctor if you do not feel better or if you feel worse WHAT IS IN THIS LEAFLET: 1. What Sennosides 7.5 mg tablets are and what they are used for 2. What you need to know before you take Sennosides 7.5 mg tablets 3. How to take Sennosides 7.5 mg tablets 4. Possible side effects 5. How to store Sennosides 7.5 mg tablets 6. Contents of the pack and other information 1. WHAT SENNOSIDES 7.5 MG TABLETS ARE AND WHAT THEY ARE USED FOR Sennosides 7.5 mg tablets are used for the short term relief of occasional constipation. This medicine does not help with weight loss. 2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE SENNOSIDES 7.5 MG TABLETS DO NOT TAKE IF YOU: • are allergic to any of the ingredients (for a full list of ingredients, see section 6) • have blockage or narrowing of the gastro-intestinal tract or bowel (ileus, intestinal obstruction or stenosis) • have paralysis or a lack of muscle tone in the bowel (atony) • have appendicitis, inflammatory bowel disease such as Crohn’s disease or ulcerative colitis • have severe dehydration • have persistent or undiagnosed abdominal complaints e.g. pain, nausea, or vomiting • have faecal impaction or rectal bleeding for which you don’t know the cause, or blood in your stools • have already taken a laxative and are still constipated • have had a sudden change in bowel habit that has lasted for more than 2 weeks • have kidney or heart failure 5. HOW TO STORE SENNOSIDES 7.5 MG TABLETS KEEP THIS MEDICINE OUT Lestu allt skjalið
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Sennosides 7.5mg tablets 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains Sennosides (as calcium salts) equivalent to 7.5mg of Hydroxyanthracene glycosides, calculated as Sennoside B. Each tablet contains 15mg of lactose monohydrate (See Section 4.4 Special warnings and precautions for use) For full list of excipients, see section 6.1 3 PHARMACEUTICAL FORM Tablets Brown coloured, speckled, circular, uncoated tablets debossed ‘BP’ on one side and ‘1’ on other side. Approximate size of the tablet is 9mm (diameter) 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS For the short term relief of occasional constipation 4.2 POSOLOGY AND METHOD OF ADMINISTRATION For oral use only The correct individual dose is the smallest required to produce a comfortable soft- formed motion. ADULTS, ELDERLY AND CHILDREN OVER 12 YEARS OLD: Two tablets taken at bedtime (Tablets should be taken as a single dose) under guidance of a medical professional. CHILDREN OVER 6-12 YEARS: One tablet to be taken at bed time. CHILDREN UNDER 6 YEARS: Not recommended. The dose should be decreased as the bowel habit becomes regular. Duration of use Usually it is sufficient to take this medicinal product up to two to three times a week. Use for more than 1 – 2 weeks requires medical supervision. If there is no bowel movement after three days, a doctor should be consulted. If laxatives are needed every day, or abdominal pain persists, a doctor should be consulted. If the symptoms worsen, or persist during the use of the medicinal product, a doctor or a pharmacist should be consulted. 4.3 CONTRAINDICATIONS Hypersensitivity to the active substance or to any of the excipients. Not to be used at the same time as other laxative agents. Cases of intestinal obstructions and stenosis, atony, appendicitis, inflammatory colon diseases (e.g Crohn’s disease, ulcerative colits), abdominal pain of unknown origin, severe dehydration state with water and electrolyte depletion. Lestu allt skjalið